[1] Kim YS, Leventhal BL. Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders[J]. Biol Psychiat, 2015,77(1):66-74. [2] Lyall K, Croen L, Daniels J, et al. The changing epidemiology of autism spectrum disorders[J]. Annu Rev Public Health, 2017,38:81-102. [3] Sharon G, Cruz NJ, Kang DW, et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice[J]. Cell, 2019,177(6):1600-1618. [4] Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders[J]. Cell, 2013,155(7):1451-1463. [5] Wang Y, Kasper LH. The role of microbiome in central nervous system disorders[J]. Brain Behav Immun, 2014,38:1-12. [6] 王宏波, 王宇鹏, 谭超超, 等. 肠道微生物与自闭症谱系障碍[J]. 中国微生态学杂志, 2020,32(1):104-107. [7] 乐涛, 卢红艳, 薛正阳, 等. 基于高通量测序分析早产认知障碍大鼠肠道菌群结构特征[J]. 中国当代儿科杂志, 2019,21(7):701-707. [8] Mosca A, Leclerc M, Hugot JP. Gut microbiota diversity and human diseases:Should we reintroduce key predators in our ecosystem?[J]. Front Microbiol, 2016,7:455. [9] 蒋海寅. 人类肠道微生物群落菌群多样性变化与抑郁症的相关性研究[D]. 杭州:浙江大学, 2015. [10] 李慧慧. 肠道菌群及短链脂肪酸与精神分裂症的相关性研究[D]. 郑州:郑州大学, 2020. [11] Kelly CR, Khoruts A, Staley C, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent clostridium difficile infection: A randomized trial[J]. Anna Intern Med, 2016,165(9):609-616. [12] Tomova A, Husarova V, Lakatosova S, et al. Gastrointestinal microbiota in children with autism in Slovakia[J]. Physiol Behav, 2015,138:179-187. [13] de Theije CG, Wopereis H, Ramadan M, et al. Altered gut microbiota and activity in a murine model of autism spectrum disorders[J]. Brain Behav Immun, 2014,37:197-206. [14] Shin NR, Whon TW, Bae JW. Proteobacteria:Microbial signature of dysbiosis in gut microbiota[J]. Trends Biotechnol, 2015,33(9):496-503. [15] Patterson E, Cryan JF, Fitzgerald GF, et al. Gut microbiota, the pharmabiotics they produce and host health[J]. Proc Nutr Soc, 2014,73(4):477-489. [16] Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis[J]. Cell, 2015,161(2):264-276. [17] Coretti L, Cristiano C, Florio E, et al. Sex-related alterations of gut microbiota composition in the BTBR mouse model of autism spectrum disorder[J]. Sci Rep, 2017,7:45-56. [18] Finegold SM, Summanen PH, Downes J, et al. Detection of Clostridium perfringens toxin genes in the gut microbiota of autistic children[J]. Anaerobe, 2017,45:133-137. [19] Braniste V, Al-Asmakh M, Kowal C, et al. The gut microbiota influences blood-brain barrier permeability in mice[J]. Sci Transl Med, 2014,6(263):158r-263r. [20] Wang L, Christophersen CT, Sorich MJ, et al. Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder[J]. Dig Dis Sci, 2012,57(8):2096-2102. [21] de la Cuesta-Zuluaga J, Mueller NT, Alvarez-Quintero R, et al. Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors[J]. Nutrients, 2018,11(1):51. [22] Kratsman N, Getselter D, Elliott E. Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model[J]. Neuropharmacology, 2016,102:136-145. [23] Liu S, Li E, Sun Z, et al. Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder[J]. Sci Rep, 2019,9(1):287. [24] MacFabe DF, Cain DP, Rodriguez-Capote K, et al. Neurobiological effects of intraventricular propionic acid in rats:Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders[J]. Behav Brain Res, 2007,176(1):149-169. [25] Gilbert KM, DeLoose A, Valentine JL, et al. Structure-activity relationship between carboxylic acids and T cell cycle blockade[J]. Life Sci, 2006,78(19):2159-2165. [26] Shaaban SY, El GY, Mehanna NS, et al. The role of probiotics in children with autism spectrum disorder: A prospective,open-label study[J]. Nutr Neurosci, 2018,21(9):676-681. |